Abstract: The present invention provides an anti-VISTA antibody which is suitable for pharmaceutical development, as pharmaceutical compositions comprising this antibody, and methods of treating VISTA-mediated diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202317069996-STATEMENT OF UNDERTAKING (FORM 3) [16-10-2023(online)].pdf | 2023-10-16 |
| 2 | 202317069996-Sequence Listing in txt [16-10-2023(online)].txt | 2023-10-16 |
| 3 | 202317069996-Sequence Listing in PDF [16-10-2023(online)].pdf | 2023-10-16 |
| 4 | 202317069996-PRIORITY DOCUMENTS [16-10-2023(online)].pdf | 2023-10-16 |
| 5 | 202317069996-POWER OF AUTHORITY [16-10-2023(online)].pdf | 2023-10-16 |
| 6 | 202317069996-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [16-10-2023(online)].pdf | 2023-10-16 |
| 7 | 202317069996-FORM 1 [16-10-2023(online)].pdf | 2023-10-16 |
| 8 | 202317069996-DRAWINGS [16-10-2023(online)].pdf | 2023-10-16 |
| 9 | 202317069996-DECLARATION OF INVENTORSHIP (FORM 5) [16-10-2023(online)].pdf | 2023-10-16 |
| 10 | 202317069996-COMPLETE SPECIFICATION [16-10-2023(online)].pdf | 2023-10-16 |
| 11 | 202317069996-Proof of Right [30-11-2023(online)].pdf | 2023-11-30 |
| 12 | 202317069996-FORM-26 [30-11-2023(online)].pdf | 2023-11-30 |
| 13 | 202317069996-FORM 3 [09-02-2024(online)].pdf | 2024-02-09 |